See all the latest news, blogs and updates from the medical sector.
World Orphan Drug Congress Europe 2025
The World Orphan Drug Congress (WODC) is dedicated to advancing the development and delivery of treatments for rare diseases. It brings together industry leaders, researchers, policymakers, patient advocates and biotech innovators.
Get involved in research more easily with RDRP's research registration
Help shape the future of rare conditions by signing up to take part in research. Find out why it's important and how to hear about research opportunities.
Bob Stevens selected for prestigious 2026 PAL Award
After reviewing numerous nominations and considering many amazing individuals, the WORLDSymposium 2026 Awards Committee has selected Bob Stevens as the recipient of the 2026 Patient Advocate Leader (PAL) Award.
Update from Bob's US tour
This week, our Chief Executive Bob Stevens and RDRP colleague Bennie Marshall-Andrews have been on a vital whirlwind tour of some of our pharma partners in the USA. Bob shares some important updates from the trip.
Supporting Siblings: How Sibs can help families affected by MPS
The MPS Society recognises how vital sibling support is. That’s why we want to spotlight Sibs - a charity offering free, practical resources for schools to help siblings feel seen and supported.
Together we can transform lives
Mountain climbs, golf marathons, a Tough Mudder and so much more! It is jam-packed! Get yourself a cuppa and enjoy the latest fundraising round-up!
The importance of clinical guidelines
Regardless of location and specialist teams, clinical guidelines exist to ensure the same high standard of care. Learn more about our involvement in their development and see which conditions have so far been published.
Now is the time: global unity for rare disease progress
We urge our global rare disease community to stand with us and demand smarter, faster and more ethical clinical trial pathways that serve the people who need them.
Time Matters: A message from the global MPS community
For families affected by neuronopathic MPS, every second counts. But too often, children are diagnosed too late to take part in clinical trials or access treatments that might help them. That’s why we are calling for urgent changes.
Together we can transform lives
Peaks, marathons, pantomimes and charity football games all awash in a sea of blue! Yes, it can only be one thing, it's time for your latest fundraising blog!